1 Table of Contents_x000D_
1.1 List of Tables_x000D_
1.2 List of Figures_x000D_
2 Introduction_x000D_
2.1 What Is This Report About?_x000D_
2.2 Diabetes Care Devices Market Segmentation_x000D_
2.3 Definitions of Markets Covered in the Report_x000D_
3 Diabetes Care Devices Market, United States_x000D_
3.1 Diabetes Care Devices Market, United States, Revenue ($m), 2018-2033_x000D_
3.2 Diabetes Care Devices Market, United States, Revenue Mix ($m), 2023_x000D_
3.3 Diabetes Care Devices Market, United States, Category Contribution by Revenue ($m), 2023_x000D_
3.4 Diabetes Care Devices Market, United States, Revenue ($m), 2018-2033_x000D_
3.5 Diabetes Care Devices Market, United States, Volume (Units), 2018-2033_x000D_
3.6 Diabetes Care Devices Market, United States, Volume (Units), 2018-2033_x000D_
3.7 Diabetes Care Devices Market, United States, Company Share by Revenue ($m), 2023_x000D_
4 Glucose Monitoring Market, United States_x000D_
4.1 Glucose Monitoring Market, United States, Revenue ($m), 2018-2033_x000D_
4.1.1 Blood Glucose Meters Market, United States, Revenue ($m), by Segment, 2018-2033_x000D_
4.2 Glucose Monitoring Market, United States, Volume (Units), 2018-2033_x000D_
4.2.1 Blood Glucose Meters Market, United States, Volume (Units), by Segment, 2018-2033_x000D_
4.3 Glucose Monitoring Market, United States, Average Price ($) , 2018-2033_x000D_
4.4 Glucose Monitoring Market, United States, Distribution Share by Revenue ($m), 2023_x000D_
4.5 Glucose Monitoring Market, United States, Company Share by Revenue ($m), 2023_x000D_
5 Insulin Delivery Market, United States_x000D_
5.1 Insulin Delivery Market, United States, Revenue Mix ($m), 2023_x000D_
5.2 Insulin Delivery Market, United States, Segment Contribution (%), 2023_x000D_
5.3 Insulin Delivery Market, United States, Revenue ($m), 2018-2033_x000D_
5.3.1 Insulin Pens Market, United States, Revenue ($m), by Segment, 2018-2033_x000D_
5.3.2 Insulin Pumps Market, United States, Revenue ($m), by Segment, 2018-2033_x000D_
5.4 Insulin Delivery Market, United States, Volume (Units), 2018-2033_x000D_
5.4.1 Insulin Pens Market, United States, Volume (Units), by Segment, 2018-2033_x000D_
5.4.2 Insulin Pumps Market, United States, Volume (Units), by Segment, 2018-2033_x000D_
5.5 Insulin Delivery Market, United States, Average Price ($) , 2018-2033_x000D_
5.6 Insulin Delivery Market, United States, Distribution Share by Revenue ($m), 2023_x000D_
5.7 Insulin Delivery Market, United States, Company Share by Revenue ($m), 2023_x000D_
6 Overview of Key Companies in United States, Diabetes Care Devices Market_x000D_
6.1 Abbott Laboratories_x000D_
6.1.1 Company Overview_x000D_
6.2 DexCom Inc_x000D_
6.2.1 Company Overview_x000D_
6.3 Eli Lilly and Co_x000D_
6.3.1 Company Overview_x000D_
6.4 Novo Nordisk AS_x000D_
6.4.1 Company Overview_x000D_
6.5 Medtronic Plc_x000D_
6.5.1 Company Overview_x000D_
6.6 Sanofi_x000D_
6.6.1 Company Overview_x000D_
6.7 Insulet Corp_x000D_
6.7.1 Company Overview_x000D_
6.8 Tandem Diabetes Care Inc_x000D_
6.8.1 Company Overview_x000D_
7 Diabetes Care Devices Market Pipeline Products_x000D_
8 Financial Deals Landscape_x000D_
8.1 Acquisition_x000D_
8.1.1 Cardinal Health to Acquire Advanced Diabetes Supply from Court Square Capital Partners for USD1.1 Billion_x000D_
8.1.2 Searle Denies Rumour to Acquire 51% Stake in Abbott Laboratories_x000D_
8.1.3 Starboard Value May Acquire Stake in Pfizer for USD1 Billion_x000D_
8.1.4 Nova Biomedical May Sell Itself_x000D_
8.1.5 Sumitomo Corporation of Americas (SCOA) Invests in Vast Medical Holdings_x000D_
8.1.6 Strive Medical Acquires ProMed DME_x000D_
8.2 Asset Transactions_x000D_
8.2.1 Trinity Biotech to Acquire Continuous Glucose Monitoring Assets(CGM) from Waveform Technologies for USD21.5 Million_x000D_
8.3 Debt Offerings_x000D_
8.3.1 Quest Diagnostics Raises USD400 Million in Public Offering of
4.60% Senior Notes Due 2027_x000D_
8.3.2 Quest Diagnostics Raises USD600 Million in Public Offering of
4.625% Senior Notes Due 2029_x000D_
8.3.3 Quest Diagnostics Raises USD850 Million in Public Offering of 5% Senior Notes Due 2034_x000D_
8.3.4 Eli Lilly Raises USD750 Million in Public Offering of
4.150% Notes due 2027_x000D_
8.3.5 Eli Lilly Raises USD1 Billion in Public Offering of
4.2% Notes due 2029_x000D_
9 Recent Developments_x000D_
9.1 Corporate Communications_x000D_
9.1.1 Oct 17, 2024: AdaptHealth Appoints Diana Nole to Board of Directors_x000D_
9.1.2 Aug 21, 2024: AGFA HealthCare Announces the UK AGFA HealthCare User Group_x000D_
9.1.3 Aug 20, 2024: Bio-Rad Appoints Jon DiVincenzo President, Chief Operating Officer_x000D_
9.1.4 Jul 18, 2024: Eyenuk Appoints Bryan Haardt as Chief Executive Officer_x000D_
9.1.5 Jul 05, 2024: Afamelanotide Assists DNA Repair Response Following UV Radiation_x000D_
9.1.6 Jun 03, 2024: Kimball Electronics Appoints New Treasurer_x000D_
9.1.7 May 31, 2024: Children’s Hospital of Philadelphia Appoints New Chief of Gastroenterology, Hepatology and Nutrition_x000D_
9.1.8 Apr 11, 2024: Pfizer Invites Shareholders to Attend Virtual-Only 2024 Annual Meeting of Shareholders on April 25_x000D_
9.1.9 Apr 08, 2024: Draper Drives Growth Strategy with Appointment of Carrie George as Chief Financial Officer_x000D_
9.1.10 Mar 06, 2024: Tandem Diabetes Care Prices Upsized Private Placement of $275.0 Million of Convertible Senior Notes Due 2029_x000D_
9.1.11 Mar 04, 2024: Tandem Diabetes Care Announces Proposed Private Placement of Convertible Notes_x000D_
9.1.12 Mar 04, 2024: Nektar Therapeutics Announces $30 Million Private Placement Financing with TCGX_x000D_
9.2 Financial Announcements_x000D_
9.2.1 Dec 12, 2024: GE HealthCare to Announce Fourth Quarter and Full Year 2024 Results on February 13, 2025_x000D_
9.2.2 Nov 26, 2024: Embecta Reports Fiscal 2024 Fourth Quarter and Full Year Financial Results; Provides Initial Fiscal Year 2025 Financial Guidance_x000D_
9.2.3 Nov 07, 2024: Nektar Therapeutics Reports Third Quarter 2024 Financial Results_x000D_
9.2.4 Oct 31, 2024: MannKind Corporation to Hold 2024 Third Quarter Financial Results Conference Call on November 7, 2024_x000D_
9.2.5 Oct 23, 2024: Thermo Fisher Scientific Announces Q3 2024 Financial Results_x000D_
9.2.6 Oct 16, 2024: Lilly Confirms Date and Conference Call for Third-Quarter 2024 Financial Results Announcement_x000D_
9.2.7 Oct 10, 2024: BD to Announce its Fiscal 2024 Fourth Quarter and Full Year Financial Results_x000D_
9.2.8 Oct 01, 2024: Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 23, 2024_x000D_
9.2.9 Sep 26, 2024: Dexcom Schedules Third Quarter 2024 Earnings Release and Conference Call for October 24, 2024 at 4:30 p.m. Eastern Time._x000D_
9.2.10 Sep 26, 2024: Integer Schedules Third Quarter 2024 Earnings Release and Conference Call for October 24, 2024_x000D_
9.2.11 Jul 25, 2024: Senseonics Holdings Schedules Second Quarter 2024 Earnings Release and Conference Call for August 8, 2024 at 4:30 P.M. Eastern Time_x000D_
9.2.12 Jul 25, 2024: Lexicon Pharmaceuticals to Host Second Quarter 2024 Financial Results Conference Call and Webcast on August 1, 2024_x000D_
9.2.13 Jul 08, 2024: Henry Schein to Webcast Second Quarter 2024 Conference Call on Tuesday, August 6, 2024 at 10:00 a.m. ET_x000D_
9.2.14 Jul 03, 2024: BD to Announce Financial Results for its Third Quarter of Fiscal 2024_x000D_
9.2.15 Jul 02, 2024: Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, July 24, 2024_x000D_
9.2.16 Jun 27, 2024: Abbott Hosts Conference Call for Second-Quarter Earnings_x000D_
9.2.17 Jun 19, 2024: Quest Diagnostics to Release Second Quarter 2024 Financial Results on July 23, 2024_x000D_
9.2.18 Jun 04, 2024: Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results_x000D_
9.2.19 May 07, 2024: Kimball Electronics Reports Q3 Results; Company Announces Renewed Strategic Focus, Including Expected Divestiture of the Automation, Test & Measurement Business_x000D_
9.2.20 May 01, 2024: MannKind Corporation to Hold 2024 First Quarter Financial Results Conference Call on May 8, 2024_x000D_
9.2.21 Apr 16, 2024: Lilly Confirms Date and Conference Call for First-Quarter 2024 Financial Results_x000D_
9.2.22 Apr 11, 2024: KORE Reports Fourth Quarter and Full Year 2023 Results; Provides Full-Year 2024 Revenue Guidance of $300 to $305 Million Driven by IoT Connectivity_x000D_
9.2.23 Apr 04, 2024: BD to Announce Financial Results for its Second Quarter of Fiscal 2024_x000D_
9.2.24 Apr 03, 2024: Insulet to Announce First Quarter 2024 Financial Results on May 9, 2024_x000D_
9.2.25 Apr 01, 2024: Scientific Industries to Host Full Year 2023 Financial Results Investor Call on April 3, 2024_x000D_
9.2.26 Mar 19, 2024: Quest Diagnostics to Release First Quarter 2024 Financial Results on April 23, 2024_x000D_
9.2.27 Feb 27, 2024: Harvard Bioscience Schedules Fourth Quarter 2023 Earnings Conference Call For March 7, 2024 at 8:00 Am ET_x000D_
9.2.28 Feb 20, 2024: MannKind Corporation to Hold 2023 Fourth Quarter and Full Year Financial Results Conference Call on February 27, 2024_x000D_
9.2.29 Jan 18, 2024: GE HealthCare to Announce Fourth Quarter and Full Year 2023 Results on February 6, 2024_x000D_
9.2.30 Jan 05, 2024: BD Announces Webcast of Annual Meeting of Shareholders_x000D_
9.2.31 Jan 04, 2024: BD to Announce Financial Results for its First Quarter of Fiscal 2024_x000D_
9.3 Government and Public Interest_x000D_
9.3.1 Dec 17, 2024: Double Medical Technology Receives 510(K) Clearance For Locking Screw CoCrMo_x000D_
9.3.2 Oct 04, 2024: Johnson & Johnson to Participate in the Guggenheim Global Healthcare Conference_x000D_
9.3.3 Jun 03, 2024: Kimball Electronics Appoints New Treasurer_x000D_
9.3.4 Jun 01, 2024: Typhoid Fever Vaccine “Tyfim V-I Injection Syringe” Information Regarding Obtaining Manufacturing and Sales Approval_x000D_
9.3.5 May 27, 2024: Qurient Unveils Q901 ASCO Abstract… Verification of safety and drug response_x000D_
9.3.6 May 21, 2024: FDA Provides Clearance to IND Application for Type 1 Diabetes Therapy SAB-142 by SAB Biotherapeutics_x000D_
9.3.7 May 21, 2024: Henry Schein to Present at Investor Conferences in June 2024_x000D_
9.3.8 May 07, 2024: Quest Diagnostics to Speak at the 2024 Leerink Partners Healthcare Crossroads Conference_x000D_
9.3.9 Apr 29, 2024: BD to Present at Bank of America Securities Health Care Conference 2024_x000D_
9.3.10 Apr 24, 2024: Merus Announces Presentation MCLA-129 at the 2024 ASCO Annual Meeting_x000D_
9.3.11 Apr 22, 2024: Johnson & Johnson to Participate in the Bernstein’s 40th Annual Strategic Decisions Conference (SDC)_x000D_
9.3.12 Apr 04, 2024: Krystal Biotech to Present at the American Association for Cancer Research 2024 Annual Meeting_x000D_
9.3.13 Apr 02, 2024: Johnson & Johnson to Participate in the BofA Securities Health Care Conference_x000D_
9.3.14 Mar 04, 2024: Biden-Harris Administration Receives Counteroffers from Drug Companies as Part of Ongoing Negotiations to Lower Drug Prices_x000D_
9.3.15 Feb 23, 2024: Edwards Lifesciences to Present at the 44th Annual TD Cowen Healthcare Conference_x000D_
9.3.16 Feb 15, 2024: BD to Present at Investor Healthcare Conferences_x000D_
9.3.17 Feb 14, 2024: GE HealthCare Management to Present at Upcoming Investor Conferences_x000D_
9.3.18 Feb 14, 2024: Johnson & Johnson to Participate in the Barclays 26th Annual Global Healthcare Conference_x000D_
9.3.19 Feb 13, 2024: Insulet to Present at The Raymond James & Associates 45th Annual Institutional Investors Conference_x000D_
9.3.20 Jan 26, 2024: Gm Dos Reis Industria E Comerico Receives FDA 510(k) Clearance for Quick – Radius Disposable Set_x000D_
9.3.21 Jan 03, 2024: Henry Schein to Present at J.P. Morgan’s Healthcare Investor Conference_x000D_
9.4 Legal And Regulatory_x000D_
9.4.1 Dec 23, 2024: Abbott Agrees to Global Continuous Glucose Monitoring Litigation Settlement with Dexcom_x000D_
9.4.2 Dec 18, 2024: Positive Results Advance Peanut Tablet to Phase II Development_x000D_
9.4.3 Dec 04, 2024: Insulet Successfully Defends its Intellectual Property Against EOFlow Co. in U.S. District Court_x000D_
9.4.4 Nov 12, 2024: ViiV Healthcare shares results from trial of Dovato and three-drug therapy for HIV_x000D_
9.4.5 Sep 11, 2024: Iantrek Announces Publication of Results of its Bio-interventional Uveoscleral Outflow Technology in Patients with Open-Angle Glaucoma_x000D_
9.4.6 Aug 14, 2024: Enrollment Completed in Phase 3 Clinical Study of Disitamab Vedotin Combined with PD-1 Inhibitor as First-Line Treatment for Urothelial Carcinoma_x000D_
9.4.7 May 14, 2024: Valcare Medical Announces Enrollment of First Two Patients in AMEND TS EU Pilot Study_x000D_
9.4.8 Feb 29, 2024: Megadyne Reiterates Intended Use Population Change for Megadyne Mega Soft Universal and Universal Plus Patient Return Electrodes_x000D_
9.5 Other Significant Developments_x000D_
9.5.1 Nov 19, 2024: Pii Expands Prefilled Syringe Services with $3.6M Investment in Capacity and Technology Upgrades_x000D_
9.5.2 Nov 19, 2024: Owen Mumford Signs Safety Phlebotomy and Specimen Collection Products Agreement With Premier_x000D_
9.5.3 Nov 18, 2024: Abbott Opens State-Of-The-Art Global Manufacturing Facility in Kilkenny, Ireland_x000D_
9.5.4 Nov 01, 2024: Insulet Announces Array of Activities to Support National Diabetes Awareness Month and World Diabetes Day in November_x000D_
9.5.5 Sep 27, 2024: Diabetic Exchange USA Introduces a Better Way to Sell Diabetic Supplies_x000D_
9.5.6 Aug 26, 2024: Ochsner Digital Medicine teams up with AmeriHealth Caritas Louisiana to improve treatment of hypertension, Type 2 diabetes_x000D_
9.5.7 Jul 29, 2024: Genpact Supports embecta''s Spin-Off into an Independent Diabetes Care Company_x000D_
9.5.8 Jul 16, 2024: Dario Expands GLP-1 Solution Client Base with New Employer Contract_x000D_
9.5.9 Jun 06, 2024: LIFE Sterilization protocol ready for the production line_x000D_
9.5.10 May 20, 2024: Vanderbilt Researchers Receive $2 Million ARPA-H Contract to Improve Software Security in Medical Devices_x000D_
9.5.11 Feb 12, 2024: Tyber Medical Acquires FDA Clearance for Proximal Tibia Plating System_x000D_
9.5.12 Jan 19, 2024: Dexcom Secures Future in Europe, Middle East, and Africa by Breaking Ground on New Manufacturing Facility in Ireland_x000D_
9.5.13 Jan 16, 2024: New Initiative Focuses on Oral Health Clinicians in Prevention and Early Detection of Heart Disease_x000D_
9.5.14 Jan 11, 2024: Veri Releases New Metabolic Health Program_x000D_
9.6 Product News_x000D_
9.6.1 Dec 04, 2024: New Study Shows Active Participation in iHealth's Unified Care Program Results in Significant Health Improvement for Patients with Stage 2 Hypertension_x000D_
9.6.2 Nov 13, 2024: Validic Advances Diabetes Care with Seamless Cgm Integration into EHR Workflows_x000D_
9.6.3 Nov 13, 2024: Healthcare Startup Focused on High-Risk Prenatal Care Launches Out of Stealth with New Platform to Modernize Gestational Diabetes Management_x000D_
9.6.4 Oct 04, 2024: BD Showcases Latest Drug Delivery Innovations at CPhI Milan 2024_x000D_
9.6.5 Oct 02, 2024: Rice’s Biotech Launch Pad to Lead Commercialization of Bioelectrical Implant Treatment for Obesity, Type 2 Diabetes_x000D_
9.6.6 Oct 01, 2024: Organogenesis Announces Publication of Randomized Clinical Trial Results Demonstrating the Safety and Efficacy of NuShield for Diabetic Foot Ulcers_x000D_
9.6.7 Sep 25, 2024: Applied Science Releases New Advanced Technologies to Improve Care for People Living With Diabetes in Rural and Under-Served Communities_x000D_
9.6.8 Aug 26, 2024: FDA Clears First Device To Enable Automated Insulin Dosing For Individuals With Type 2 Diabetes_x000D_
9.6.9 Aug 13, 2024: New UH Study Targets Early Signs of Vision Loss in Diabetic Patients_x000D_
9.6.10 Jun 24, 2024: American Diabetes Association Showcases Innovations and Guidance for Early Risk Monitoring of Type 1 Diabetes_x000D_
9.6.11 Jun 24, 2024: Embecta-Sponsored Abstracts Presented at American Diabetes Association’s 84th Scientific Sessions Highlight Unmet Need for Patch Pumps With 300U Insulin Reservoir_x000D_
9.6.12 Jun 10, 2024: Health for Mankind Company Launches DIABIMETRICS, A Bold Step Towards Revolutionizing Diabetes Management and Eliminating Health Disparities_x000D_
9.6.13 May 21, 2024: YPrime Transforms Endocrinology and Autoimmune Trials through New Glucometer and eCOA Integrated Functionality_x000D_
9.6.14 May 02, 2024: Adding AI to Artificial Pancreas Enhances Efficiency, Study Finds_x000D_
9.6.15 Apr 05, 2024: Know Labs to Present Clinical Research at the 2024 American Physiology Summit_x000D_
9.6.16 Mar 06, 2024: embecta-sponsored Educational Symposium and Abstracts at ATTD Highlight Role of Insulin Pumps in the Management of Type 2 Diabetes_x000D_
9.6.17 Mar 06, 2024: Real-World Data Show Abbott's FreeStyle Libre Systems and GLP-1 Medicines Work Better Together for People with Type 2 Diabetes_x000D_
9.6.18 Mar 06, 2024: AI Can Speed Design of Health Software_x000D_
9.6.19 Jan 26, 2024: New Study: Biomarkers That Improve Prediction of Cardiovascular Disease in Type 2 Diabetes_x000D_
9.6.20 Jan 24, 2024: Modular Medical Announces Issuance of New US Patent_x000D_
9.6.21 Jan 23, 2024: Know Labs to Exhibit at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)_x000D_
9.6.22 Jan 04, 2024: Lilly Launches End-to-End Digital Healthcare Experience through LillyDirect_x000D_
9.7 Research And Development_x000D_
9.7.1 Feb 12, 2024: Health Canada Approves Keytruda in Combination With Trastuzumab and Chemotherapy, as a First-Line Treatment for Metastatic HER2-Positive Gastric_x000D_
9.8 Strategy And Business Planning_x000D_
9.8.1 Dec 04, 2024: Avant Technologies Partner, Ainnova, Signs Pilot Program With Roche to Combat Diabetic Retinopathy_x000D_
9.8.2 Nov 18, 2024: Abbott Launches Global Manufacturing Facility in Kilkenny, Ireland_x000D_
9.8.3 Nov 18, 2024: Abbott Opens State-Of-The-Art Global Manufacturing Facility in Kilkenny, Ireland_x000D_
9.8.4 Oct 01, 2024: Glytec and Ardent Partner to Boost Diabetes and Insulin Management Nationwide_x000D_
9.8.5 Sep 24, 2024: Rimidi Increases Customer Base by 400%, Expands Partnerships and Services in 2024 to Support Future Growth_x000D_
9.8.6 Sep 14, 2024: RYBREVANT (Amivantamab) Plus Chemotherapy Show 49 Percent Overall Response Rate in Metastatic Colorectal Cancer_x000D_
9.8.7 Aug 26, 2024: Ochsner Digital Medicine teams up with AmeriHealth Caritas Louisiana to improve treatment of hypertension, Type 2 diabetes_x000D_
9.8.8 May 14, 2024: Glytec and University Hospitals (UH) Forge Strategic Partnership_x000D_
9.8.9 Apr 18, 2024: Glytec Announces Support for Landmark New CMS Measures to Improve Diabetes Reporting_x000D_
9.8.10 Mar 08, 2024: New Data Published by Omada Health Demonstrates the Impact of Coupling GLP-1s and Behavior Change Programming_x000D_
9.8.11 Feb 08, 2024: Ubiquitech Software Unveils Groundbreaking Lifestyle Video Marketing Initiative for Innovative Outcomes Driving Rapid Company Growth_x000D_
9.8.12 Jan 17, 2024: Fitbit and Quest Diagnostics Collaborate to Advance Research on the Use of Wearable Devices to Improve Metabolic Health_x000D_
9.8.13 Jan 16, 2024: Orbis International and Nidek Join Forces to Scale Up Artificial Intelligence Eye Screenings in Vietnam_x000D_
10 Appendix_x000D_
10.1 Research Methodology_x000D_
10.1.1 Coverage_x000D_
10.1.2 Secondary Research_x000D_
10.1.3 Primary Research_x000D_
10.1.4 Market Modeling and Forecasting_x000D_
10.1.5 Company Share Analysis_x000D_
10.1.6 Distribution Share Analysis_x000D_
10.1.7 Benchmarking_x000D_
10.2 GlobalData Consulting_x000D_
10.3 Contact Us_x000D_
10.4 Disclaimer
